Rosemont Pharmaceuticals Overview

  • Year Founded
  • 1967

Year Founded

  • Status
  • Private

  • Employees
  • 283

Employees

  • Latest Deal Type
  • Fund - Cont Trans

  • Financing Rounds
  • 6

  • Investments
  • 5

Rosemont Pharmaceuticals General Information

Description

Manufacturer of oral liquid formulations of off-patent and solid-dose pharmaceutical products intended for patients with swallowing difficulties. The company offers liquid and solid medications and also provides medicines for anesthesia, the cardiovascular system, the central nervous system, the endocrine system, the gastrointestinal system, infections, malignant disease and immunosuppression, and other diseases, thereby enabling patients to improve their health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Rosemont House
  • Yorkdale Industrial Park, Braithwaite Street
  • Leeds LS11 9XE
  • England, United Kingdom
+44 0113
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • Rosemont House
  • Yorkdale Industrial Park, Braithwaite Street
  • Leeds LS11 9XE
  • England, United Kingdom
+44 0113

Rosemont Pharmaceuticals Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rosemont Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rosemont Pharmaceuticals‘s full profile, request access.

Request a free trial

Rosemont Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of oral liquid formulations of off-patent and solid-dose pharmaceutical products intended for patients with
Pharmaceuticals
Leeds, United Kingdom
283 As of 2025

Berkhamsted, United Kingdom
 

Basingstoke, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rosemont Pharmaceuticals Competitors (3)

One of Rosemont Pharmaceuticals’s 3 competitors is Bristol Laboratories, a Corporation company based in Berkhamsted, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bristol Laboratories Corporation Berkhamsted, United Kingdom
Crescent Pharma Corporation Basingstoke, United Kingdom
Laxmi Bns Holdings Corporation Ruislip, United Kingdom
You’re viewing 3 of 3 competitors. Get the full list »

Rosemont Pharmaceuticals Patents

Rosemont Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202407814-D0 Phenobarbital oral composition and method of manufacture/use thereof Inactive 03-Jun-2024
WO-2025253095-A1 Phenobarbital oral composition and method of manufacture/use thereof Pending 03-Jun-2024
CA-3168005-A1 Liquid pharmaceutical composition of clonidine Pending 20-Jul-2021
EP-4122450-A1 Liquid pharmaceutical composition of clonidine Pending 20-Jul-2021
GB-202110420-D0 Liquid pharmaceutical composition of clonidine Inactive 20-Jul-2021 A61K9/0095
To view Rosemont Pharmaceuticals’s complete patent history, request access »

Rosemont Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rosemont Pharmaceuticals Investments (5)

Rosemont Pharmaceuticals’s most recent deal was a Buyout/LBO with Aytu Biopharma. The deal was made on 16-Nov-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Aytu Biopharma 16-Nov-2026 Buyout/LBO Pharmaceuticals
Sabal Therapeutics 08-Jul-2024 Buyout/LBO Other Healthcare Services
Pharma-Data 20-Jun-2024 Buyout/LBO Other Pharmaceuticals and Biotechnology
Lucis Pharma 16-Jun-2023 Buyout/LBO Pharmaceuticals
Essential Pharma (UK Oral Liquid Portfolio) 25-Nov-2021 Buyout/LBO Buildings and Property
To view Rosemont Pharmaceuticals’s complete investments history, request access »

Rosemont Pharmaceuticals Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Sabal Therapeutics Watkinsville, GA 2016
Lucis Pharma Leeds, United Kingdom 2012
Pharma-Data Lavrion, Greece 2000

Rosemont Pharmaceuticals FAQs

  • When was Rosemont Pharmaceuticals founded?

    Rosemont Pharmaceuticals was founded in 1967.

  • Where is Rosemont Pharmaceuticals headquartered?

    Rosemont Pharmaceuticals is headquartered in Leeds, United Kingdom.

  • What is the size of Rosemont Pharmaceuticals?

    Rosemont Pharmaceuticals has 283 total employees.

  • What industry is Rosemont Pharmaceuticals in?

    Rosemont Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Rosemont Pharmaceuticals a private or public company?

    Rosemont Pharmaceuticals is a Private company.

  • What is Rosemont Pharmaceuticals’s current revenue?

    The current revenue for Rosemont Pharmaceuticals is .

  • How much funding has Rosemont Pharmaceuticals raised over time?

    Rosemont Pharmaceuticals has raised $13M.

  • Who are Rosemont Pharmaceuticals’s competitors?

    Bristol Laboratories, Crescent Pharma, and Laxmi Bns Holdings are competitors of Rosemont Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process